Objective:To investigate the heterogeneity of chemosensitivity in bladder cancer using an ATP-tumor chemosensitivity assay (ATP-TCA) and the feasibility of individual chemotherapy.

But it did not target normal tissue, or tumor tissues in other parts of the body including the colon, kidney, cervix, pancreas, lung, skin or bladder, the study showed.

And a team from the Spanish National cancer Research Center offered indications that a new way of analyzing antibodies in the blood could lead to a non-invasive way to screen for bladder cancer.